神经生长因子IB
细胞凋亡
癌症研究
线粒体
癌细胞
程序性细胞死亡
细胞生物学
核受体
生物
激活剂(遗传学)
化学
受体
癌症
转录因子
生物化学
遗传学
基因
作者
Xiaohong Chen,Meichun Gao,Yongzhen Xia,Xin Wang,Jingbo Qin,Hongying He,Weirong Liu,Xiaowei Zhang,Shuangzhou Peng,Zhiping Zeng,Ying Su,Xiao-kun Zhang
标识
DOI:10.1016/j.apsb.2023.11.017
摘要
The orphan nuclear receptor Nur77 is a critical regulator of the survival and death of tumor cells. The pro-death effect of Nur77 can be regulated by its interaction with Bcl-2, resulting in conversion of Bcl-2 from a survival to killer. As Bcl-2 is overexpressed in various cancers preventing them from apoptosis and promoting their resistance to chemotherapy, targeting the apoptotic pathway of Nur77/Bcl-2 may lead to new cancer therapeutics. Here, we report our identification of XS561 as a novel Nur77 ligand that induces apoptosis of tumor cells by activating the Nur77/Bcl-2 pathway. In vitro and animal studies revealed an apoptotic effect of XS561 in a range of tumor cell lines including MDA-MB-231 triple-negative breast cancer (TNBC) and MCF-7/LCC2 tamoxifen-resistant breast cancer (TAMR) in a Nur77-dependent manner. Mechanistic studies showed XS561 potently induced the translocation of Nur77 from the nucleus to mitochondria, resulting in mitochondria-related apoptosis. Interestingly, XS561-induced accumulation of Nur77 at mitochondria was associated with XS561 induction of Nur77 phase separation and the formation of Nur77/Bcl-2 condensates. Together, our studies identify XS561 as a new activator of the Nur77/Bcl-2 apoptotic pathway and reveal a role of phase separation in mediating the apoptotic effect of Nur77 at mitochondria.
科研通智能强力驱动
Strongly Powered by AbleSci AI